Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic
-Acre-scale seed production planned in spring 2022
-First winter PHA Camelina planting expected in fall 2022
-Research program to produce PHA co-polymers is underway
“Camelina holds great promise as a platform crop for efficient, scalable, low-cost production of PHA bioplastics,” said
Yield10 plans to breed an optimized PHA trait into the elite herbicide and disease resistant varieties of Camelina currently advancing in its pipeline with the expectation to process PHA Camelina to achieve the integrated economics of simultaneously producing three seed products: PHA bioplastic, feedstock oil and protein animal feed. Seed based PHA bioplastic would represent a major new market for farmers.
Summary of Yield10’s
Utilizing a metabolic engineering approach, Yield10 deployed a pathway for producing PHA bioplastic in the seed of Camelina. Recent advancements include:
2022 Seed Scale up Plan: Permitting is underway to plant PHA (C3015) Camelina line at acre-scale this year. This will enable production of PHA for process development and product sampling.
Development of winter PHA Camelina lines: Yield10 has recently developed winter Camelina varieties containing the PHA (C3014 and C3015) trait. The first field planting of these lines is planned for winter 2022/2023.
Ongoing Second-Generation R&D Program: Yield10’s ongoing second-generation research and development program is focused on improving the level of PHA in the seed of Camelina to 10-20 percent. In addition, work is underway to create PHA pathways that enable the production of PHA co-polymers in Camelina. The successful production of PHA co-polymers would expand the range of properties available for PHA produced in Camelina resulting in broader target applications.
Background on PHA Bioplastics
Global plastic waste is estimated at 380 million metric tons per year. The largest market for plastics today is for packaging materials, and it accounts for nearly half of all plastic waste generated globally, where most of it is never recycled or incinerated. We believe there may be significant market opportunity for producing PHA biomaterials in Camelina in the future. PHA biomaterials (PHAs) are natural microbial high molecular weight polymeric storage polymers. These polymers are natural polyesters and can be recovered from the microbes which produce them and processed using standard plastics processing equipment into a range of product forms. The production of PHA bioplastics in Camelina could represent an entirely new market opportunity for farmers. This opportunity could provide economic returns for farmers to justify large acreage adoption of Camelina as a cover crop and enable the low-cost production of this product for new markets including water treatment and sustainable biodegradable plastics replacement applications.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, statements regarding Camelina’s promise as a platform crop for efficient, scalable, low-cost production of PHA bioplastics; the Company’s expectation that it will contribute significantly towards the global effort to produce biodegradable materials; the Company’s momentum driving the Company’s innovative pace of Camelina PHA trait development and its ultimate commercial deployment for year-round harvest; the Company’s plans to breed the PHA trait into elite herbicide and disease resistant varieties of Camelina; the Company’s expectation for PHA Camelina to achieve the integrated economics of simultaneously producing three seed products; the Company’s intentions with regard to the 2022 seed scale up plan, enabling production of PHA for sampling, and the winter 2022/2023 planting schedule; the Company’s expectations with respect to improving the level of PHA to 10-20 percent, enabling the production of PHA co-polymers in Camelina and the potential range of properties available for PHA produced in Camelina; and the Company’s belief about the market opportunity for producing PHA biomaterials in Camelina, the production of PHA bioplastics as a market opportunity for farmers, and the potential economic returns for farmers to justify large acreage adoption of Camelina as a cover crop constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in
Managing Director, CORE IR
Source: Yield10 Bioscience, Inc.